Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
2.
J Investig Med ; 61(6): 1026-9, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23851960

RESUMO

BACKGROUND: Since 2002, the incidence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections (SSTIs) has been steadily increasing and CA-MRSA may now account for most community-based SSTIs. Although consensus remains vague, using antibiotics with MRSA coverage has shown improved rates of clinical resolution. The goal of this pilot study was to assess resident physicians' awareness and management of CA-MRSA SSTIs in the acute/ambulatory care setting. METHODS: This is a prospective cross-sectional survey-design study based on clinical case scenarios approved by the university's institutional review board. The survey was distributed to residents in internal medicine, general surgery, and emergency medicine. The survey was designed to assess (1) their knowledge of MRSA prevalence in community SSTIs and (2) their choice of empiric antibiotic for community-based SSTIs. RESULTS: Across all residency programs, only 15.7% of residents correctly estimated prevalence of CA-MRSA in SSTIs in the acute care/ambulatory setting to be 50% or higher. In practice, 28.6% of general surgery residents, 50.0% of internal medicine residents, and 69.7% of emergency medicine residents would use an antibiotic with appropriate MRSA coverage. CONCLUSION: This pilot study reveals that a substantial number of resident physicians are unaware of the increasing prevalence of CA-MRSA SSTIs and continue to use ß-lactam antibiotics for empiric pharmacotherapy of community-based SSTIs. More education is desperately needed on this crucial topic across various residency training programs.


Assuntos
Competência Clínica/normas , Educação Médica Continuada/normas , Internato e Residência/normas , Staphylococcus aureus Resistente à Meticilina , Infecções dos Tecidos Moles/terapia , Infecções Estafilocócicas/terapia , Infecções Comunitárias Adquiridas/diagnóstico , Infecções Comunitárias Adquiridas/terapia , Estudos Transversais , Humanos , Internato e Residência/métodos , Projetos Piloto , Estudos Prospectivos , Método Simples-Cego , Infecções dos Tecidos Moles/diagnóstico , Infecções Estafilocócicas/diagnóstico , Infecções Cutâneas Estafilocócicas/diagnóstico , Infecções Cutâneas Estafilocócicas/terapia
3.
Surgery ; 146(1): 23-30, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19541007

RESUMO

BACKGROUND: We previously evaluated cardioprotective effects of glucose-insulin-potassium (GIK) in a porcine ischemia-reperfusion model; our results showed less myocardial pH decrease during ischemia and reperfusion and faster normalization of ATP and glucose during reperfusion. The proposed protective mechanism was facilitation of glucose transport for myocardial metabolism. The objective of this study was to assess the impact of insulin-potassium (IK) alone on myocardial metabolism. METHODS: Male swine received continuous infusion of IK (IK group, n = 10), GIK (GIK group, n = 10), or standard lactated Ringer's (LR) solution (controls, n = 10). Induction of 20 minutes of ischemia in the left anterior descending (LAD) artery distribution was followed by 20 minutes of reperfusion. Real-time biosensors recorded pH and glucose levels in ischemic and nonischemic beds. Myocardial biopsies in the distribution of the LAD assessed ATP levels. Groups were compared using the Kruskal-Wallis and Mann-Whitney tests. RESULTS: Real-time data are presented as percent change from baseline. At less than 10 minutes of ischemia, the average pH change was less for the IK group than the LR group (0.03% +/- 0.21% vs -2.06% +/- 1.23%; P = .001), and the pH change in the IK group was similar to the GIK group. After 10 minutes of ischemia and during the first 10 minutes of reperfusion, the IK group experienced pH changes that were similar to the LR group. Biopsies after 20 minutes of ischemia and 20 minutes of reperfusion showed less of a decline in ATP levels for the IK group compared to the LR group. Glucose at all time points demonstrated no statistically significant differences. CONCLUSION: IK infusion alone demonstrates cardioprotective effects during early ischemia; however, compared to GIK infusion after 20 minutes of ischemia and reperfusion, myocardial pH and glucose levels were not sustained. Although insulin may facilitate glucose transport during ischemia, additional glucose in combination with IK enhances myocardial protection during reperfusion. This finding suggests that GIK enhancement during acute ischemia-reperfusion may improve myocardial protection.


Assuntos
Insulina/uso terapêutico , Traumatismo por Reperfusão Miocárdica/prevenção & controle , Miocárdio/metabolismo , Potássio/uso terapêutico , Trifosfato de Adenosina/metabolismo , Animais , Biópsia , Modelos Animais de Doenças , Glucose/administração & dosagem , Glucose/metabolismo , Glucose/uso terapêutico , Concentração de Íons de Hidrogênio , Infusões Intra-Arteriais , Insulina/administração & dosagem , Insulina/metabolismo , Masculino , Traumatismo por Reperfusão Miocárdica/metabolismo , Miocárdio/patologia , Potássio/administração & dosagem , Potássio/metabolismo , Suínos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA